Wyeth Appeals Rulings In Womens’ Breast Cancer Cases

Las Vegas (dbTechno) - Pharmaceutical giant Wyeth has announced that they have filed an appeal in regards to the court ruling in favor of three women from Nevada, as well as an Arkansas case. The three women were awarded $58 million, as the court agreed that one of Wyeth’s drugs caused their breast cancer. The drugs in question are Premarin and Prempro.

Wyeth filed the appeal in court on Wednesday, asking for an overturn of the February 21st ruling by Washoe County District Judge Robert Perry.

They filed the appeal with the Nevada Supreme Court.

Premarin and Prempro, the drugs in question, is in the middle of more than 5,000 similar lawsuits which Wyeth is now facing.

The first drug, Premarin, is an estrogen replacement drug, while the second, Prempro, is a combo drug, combining estrogen and progestin.

The drugs are given to women to help them get through menopause.

They have already filed an appeal for the Nevada case, where $58 million was awarded to 74-year-old Jeraldine Scofield, 68-year-old Arlene Rowatt, and 65-year-old Pamela Forrester.

They are also going to likely appeal another ruling in Arkansas, where they were ordered to pay $27 million to a women who got breast cancer from the drugs.